{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:29:14Z","timestamp":1771342154603,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12185-025-04075-0","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:33:12Z","timestamp":1759383192000},"page":"291-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tertiary prophylaxis with extended half-life factor prophylaxis: a model to reduce disability in low- and middle-income countries"],"prefix":"10.1007","volume":"123","author":[{"given":"Archit S.","family":"Pandharipande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silky","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eby P.","family":"Baby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hari","family":"Gaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudipto","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditi","family":"Tulsiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savitri","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-5641","authenticated-orcid":false,"given":"Nita","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"2","key":"4075_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12288-019-01233-3","volume":"36","author":"T Sahoo","year":"2020","unstructured":"Sahoo T, Naseem S, Ahluwalia J, Marwaha RK, Trehan A, Bansal D. Inherited bleeding disorders in North Indian children: 14 years\u2019 experience from a tertiary care center. Indian J Hematol Blood Transfus. 2020;36(2):330\u20136. https:\/\/doi.org\/10.1007\/s12288-019-01233-3.","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"4075_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000488060","volume":"45","author":"L Graf","year":"2018","unstructured":"Graf L. Extended half-life factor VIII and factor IX preparations. Transfus Med Hemother. 2018;45(2):86\u201391. https:\/\/doi.org\/10.1159\/000488060.","journal-title":"Transfus Med Hemother"},{"issue":"3","key":"4075_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4274\/tjh.galenos.2019.2018.0393","volume":"36","author":"MC Ar","year":"2019","unstructured":"Ar MC, Balkan C, Kavakl\u0131 K. Extended half-life coagulation factors: a new era in the management of hemophilia patients. Turk J Haematol. 2019;36(3):141\u201354. https:\/\/doi.org\/10.4274\/tjh.galenos.2019.2018.0393.","journal-title":"Turk J Haematol"},{"issue":"5","key":"4075_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1586\/17474086.2014.951322","volume":"7","author":"JM Ducore","year":"2014","unstructured":"Ducore JM, Miguelino MG, Powell JS. Alprolix (recombinant factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B. Expert Rev Hematol. 2014;7(5):559\u201371. https:\/\/doi.org\/10.1586\/17474086.2014.951322.","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"4075_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 2020;26(6):1\u2013158. https:\/\/doi.org\/10.1111\/hae.14046.","journal-title":"Haemophilia"},{"key":"4075_CR6","first-page":"75","volume":"1","author":"SP Verma","year":"2021","unstructured":"Verma SP, Tripathi AK, Sharma GS, Kumar N, Kushwaha R. Low dose long-acting factor VIII prophylaxis in pediatric and young adult patients with hemophilia A: short-term single-center experience from a developing country. J Hematol Allied Sci. 2021;1:75\u201380.","journal-title":"J Hematol Allied Sci"},{"issue":"8","key":"4075_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1055\/s-0035-1552563","volume":"41","author":"MD Carcao","year":"2015","unstructured":"Carcao MD, Iorio A. Individualizing factor replacement therapy in severe hemophilia. Semin Thromb Hemost. 2015;41(8):864\u201371.","journal-title":"Semin Thromb Hemost"},{"key":"4075_CR8","unstructured":"World Federation of Hemophilia report on the Annual Global Survey 2022. Accessed at https:\/\/www1.wfh.org\/publications\/files\/pdf-2399.pdf on 05 September 2024."},{"issue":"3","key":"4075_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/joah.joah_37_19","volume":"10","author":"PK Mandal","year":"2019","unstructured":"Mandal PK, Phukan Abhijit1, Bhowmik Amrita1, Gantait Debasis1, Chakrabarti Prantar1. Effect of tertiary prophylaxis with low-dose factor VIII in quality of life in adult patients with severe hemophilia A. J Appl Hematol. 2019;10(3):88\u201393. https:\/\/doi.org\/10.4103\/joah.joah_37_19.","journal-title":"J Appl Hematol"},{"issue":"9","key":"4075_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00209-5","volume":"9","author":"GF Pierce","year":"2022","unstructured":"Pierce GF, Adediran M, Diop S, Dunn AL, El Ekiaby M, Kaczmarek R, et al. Achieving access to haemophilia care in low-income and lower-middle-income countries: expanded humanitarian aid program of the World Federation of Hemophilia after 5 years. Lancet Haematol. 2022;9(9):e689\u2013e697. https:\/\/doi.org\/10.1016\/S2352-3026(22)00209-5.","journal-title":"Lancet Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04075-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04075-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04075-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:50:40Z","timestamp":1771339840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04075-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4075"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04075-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional ethics committee approval was taken before the start of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patient consent was taken before enrolling the patients into the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"Extended half-life clotting factors in management of hemophilia. Presented on 15 and 16th September, Asia pacific meeting of association of Hemophilia and allied disorders, Bangkok.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conference presentation"}}]}}